0.11
0.11 (-43.25%)
As of Jan 04, 2024
Nemaura Medical Inc. [NMRD]
Source:
Company Overview
Nemaura Medical Inc. is a medical technology company that has developed sugar BEAT, a non-invasive, flexible, continuous glucose monitoring system, for adjunctive use by persons with diabetes, and any person wishing to determine factors influencing their blood glucose profiles.
| Country | United States |
| Headquarters | new york, new york |
| Phone Number | 646 - 416-8000 |
| Industry | manufacturing |
| CEO | Dr. D.F.H.Chowdhury |
| Website | www.nemauramedical.com |
Financial Year:
Financial Overview (Dollars in Millions)
| Revenue | $0 |
| Operating Profit | $-1.5 |
| Net Income | $-2.2 |
| Net Cash | $-10 |
Profit Ratios
| Gross Margin | $0 |
| Operating Margin | |
| Profit as % of Revenues | |
| Profit as % of Assets | -21.9% |
| Profit as % of Stockholder Equity | 12.1% |
Management Effectiveness
| Return on Equity | 12.1% |
| Return on Assets | -41.8% |
| Turnover Ratio | 0% |
| EBITA |
Balance Sheet and Cash Flow Measures
| Total Assets | $5.2 |
| Total Liabilities | $23 |
| Operating Cash Flow | $-7.2 |
| Investing Cash Flow | $-0.1 |
| Financing Cash Flow | $-2.7 |
